Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 15/20 | 0.54 |
| ▸ | NPC1 | O15118 | 3/20 | 0.38 |
| ▸ | RAB9A | P51151 | 3/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.38 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.38 |
| ▸ | NFKB2 | Q00653 | 2/20 | 0.38 |
| ▸ | RELA | Q04206 | 2/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | TP53 | P04637 | 2/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | PKM | P14618 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19271449 | 0.93 | PDK2 (0.48) | PDK2NPC1RAB9ANFKB1NFKB2 | |
| SCHEMBL19164605 | 0.93 | PDK2 (0.47) | PDK2NPC1RAB9ANFKB1NFKB2 | |
| SCHEMBL19116716 | 0.91 | PDK2 (0.62) | PDK2 | |
| SCHEMBL17151653 | 0.90 | PDK2 (0.48) | PDK2NPC1RAB9ASMN1; SMN2NFKB1 | |
| SCHEMBL25464734 | 0.90 | PDK2 (0.44) | PDK2NPC1RAB9ANFKB1NFKB2 | |
| SCHEMBL25946577 | 0.90 | PDK2 (0.44) | PDK2NPC1RAB9ANFKB1NFKB2 | |
| SCHEMBL19164072 | 0.89 | PDK2 (0.46) | PDK2NPC1RAB9ASMN1; SMN2NFKB1 | |
| SCHEMBL21945335 | 0.89 | PDK2 (0.47) | PDK2NPC1RAB9ANFKB1NFKB2 | |
| SCHEMBL18878322 | 0.89 | PDK2 (0.50) | PDK2NPC1RAB9ASMN1; SMN2L3MBTL1 | |
| SCHEMBL17151586 | 0.89 | PDK2 (0.50) | PDK2NPC1RAB9ASMN1; SMN2L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8475940-B2 | Anthracene derivative and light-emitting device | TOPPAN PRINTING CO., LTD. (JP) | 2013-07-02 | — | — | US | disclosed |
| US-8475940-B2 | Anthracene derivative and light-emitting device | TOPPAN PRINTING CO., LTD. (JP) | 2013-07-02 | — | — | US | disclosed |
| US-20120248973-A1 | ANTHRACENE DERIVATIVE AND LIGHT-EMITTING DEVICE | TOPPAN PRINTING CO., LTD. (JP) | 2012-10-04 | — | — | US | disclosed |
| US-20120248973-A1 | ANTHRACENE DERIVATIVE AND LIGHT-EMITTING DEVICE | TOPPAN PRINTING CO., LTD. (JP) | 2012-10-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120248973-A1 | ANTHRACENE DERIVATIVE AND LIGHT-EMITTING DEVICE | ARL1, AHR, CRY2 | PDK2 3200/4885NPC1 3262/4885RAB9A 1735/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.